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Main Outcome Measures

82
Retinal cone density, estimated GC density and cone:GC ratios in glaucoma patients 83 and healthy controls. 
Conclusions
95
Local measurements of cone density do not differ significantly from normal in glaucoma 96 patients despite large differences in GC density. There was no statistically significant 97 association between GC density and cone density in the normal participants, and the 98 range of cone:GC density ratios was relatively large in healthy controls. These findings 99 suggest that estimates of baseline GC density from cone density are unlikely to be 100 precise, and offer little advantage over determination of GC alone in the identification 101 of early glaucomatous change.
Introduction
107
Between-individual variability in retinal ganglion cell (GC) density in healthy human 108 eyes is known to be high. 1 As a result, when a patient suspected of having glaucoma 109 presents for the first time, it is difficult to determine whether a clinical measurement 110 relating to GC density (e.g., conventional perimetry, peripheral grating resolution acuity
111
[PGRA], or imaging parameter) is normal for the individual or already represents a 112 change from that individual's original baseline. If, however: a) the cone:GC ratio is 113 relatively similar between normal individuals (despite large inter-individual variation in 114 both cone and GC density), and b) the number of cones remains stable in glaucoma
115
(despite a decline in GC density), then objective cone density measures could be used
116
as a means to determine the original baseline GC density and thus help to identify 117 early GC loss in glaucoma without a lengthy longitudinal investigation.
118
While the death of retinal GC is a hallmark of glaucoma, the notion of a loss of 
Methods
139
Participants
140
The study protocol was approved by both the relevant National Health Service In vivo cone imaging using a modified small-angle HRA2
216
A standard HRA2 (Heidelberg Engineering GmbH, Heidelberg, Germany) was and were plotted as single white pixels on a black background. To ensure the identified 246 cones were not closer than physiologically possible, the binary blobs were each dilated 247 using a white disk of diameter 2 pixels (i.e., if inter-cone spacing were too small, the 248 given identified cones would no longer be spatially independent following dilation).
249
Following this, each remaining spatially independent blob was counted as a cone. This Table 2 ). Figure 4 shows the fundus image of a glaucoma patient with a paracentral 298 scotoma in the superior visual field and corresponding reduced RNFL thickness and
299
GC density in the inferior retina.
300
There was no statistically significant difference in cone density between Table 2 ). There was no statistically significant inter-location difference in 305 cone density within each group (glaucoma: P = 0.44; healthy controls: P = 0.75).
306
Cone density and GC density were not significantly associated in either 307 hemifield in the healthy or glaucomatous group (Fig 5 A, C) . There was a statistically 308 significant relationship between DLS and log estimated GC density in both retinal and log cone density in either group.
312
Median cone:GC density ratio was 3. hemifield) between glaucoma patients and healthy subjects (P > 0.05, Table 2 ).
318
Cone:GC density ratios showed a large range in healthy controls (Fig 5 E) astigmatism or unsteady fixation) or some, as yet, unknown change in the retina (e.g.
426
refractive index changes).
427
In conclusion, our results did not show any notable advantage in using cone:
428
GC ratios over GC density alone for identifying glaucoma. Cone:GC density ratios and (GC) and cone density, and cone:GC ratio to detect glaucoma. 
